Digitoxin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Digitoxin''' is a [[cardiac glycoside]], a type of drug that can increase the force of heart contractions, control heart rate, and alleviate symptoms of [[heart failure]]. It is derived from the leaves of the [[Digitalis purpurea]] plant, also known as the purple foxglove.
== Digitoxin ==


== History ==
[[File:Digitoxin_structure.svg|thumb|right|Chemical structure of Digitoxin]]


Digitoxin was first isolated in 1875 by the English physician Sir [[William Withering]], who recognized the therapeutic potential of Digitalis purpurea in treating heart conditions. It has been used in medical practice for over a century.
'''Digitoxin''' is a cardiac glycoside that is derived from the [[Digitalis]] plant, commonly known as foxglove. It is used in the treatment of certain heart conditions, particularly [[heart failure]] and [[atrial fibrillation]]. Digitoxin works by increasing the force of contraction of the heart muscle, thereby improving cardiac output.


== Pharmacology ==
=== Mechanism of Action ===


Digitoxin works by inhibiting the [[sodium-potassium ATPase]] pump in the membranes of heart cells. This increases the amount of calcium inside the cells, which strengthens heart contractions and slows the heart rate.  
Digitoxin exerts its effects by inhibiting the [[sodium-potassium pump]] (Na_/K_-ATPase) in cardiac cells. This inhibition leads to an increase in intracellular sodium levels, which in turn affects the sodium-calcium exchange mechanism, resulting in increased intracellular calcium. The elevated calcium levels enhance the contractility of the heart muscle, a phenomenon known as positive inotropic effect.


== Medical Uses ==
=== Pharmacokinetics ===


Digitoxin is used to treat various heart conditions, including [[atrial fibrillation]], [[atrial flutter]], and heart failure. It can be used when other treatments are ineffective or contraindicated.
Digitoxin is characterized by its long half-life, which can range from 5 to 7 days. It is primarily metabolized in the liver and excreted in the bile. Unlike [[digoxin]], another cardiac glycoside, digitoxin is not significantly excreted by the kidneys, making it a suitable option for patients with renal impairment.


== Side Effects ==
=== Clinical Uses ===


Common side effects of digitoxin include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. More serious side effects can include [[cardiac arrhythmias]], [[hyperkalemia]], and [[digitalis toxicity]], which can be life-threatening.
Digitoxin is used in the management of chronic heart failure and certain types of arrhythmias, such as atrial fibrillation. It helps to control the heart rate and improve symptoms of heart failure by enhancing cardiac output.


== Contraindications ==
=== Side Effects ===


Digitoxin is contraindicated in patients with [[ventricular fibrillation]], [[hypertrophic cardiomyopathy]], and certain types of heart block. It should be used with caution in patients with kidney disease, as it is primarily excreted by the kidneys.
Common side effects of digitoxin include nausea, vomiting, diarrhea, and dizziness. More serious side effects can occur, such as [[arrhythmias]], [[bradycardia]], and [[digitalis toxicity]]. Monitoring of blood levels and clinical symptoms is essential to avoid toxicity.


== See Also ==
=== Digitalis Toxicity ===


Digitalis toxicity is a serious condition that can occur with digitoxin use, especially in cases of overdose or in patients with impaired metabolism. Symptoms of toxicity include gastrointestinal disturbances, confusion, visual changes, and cardiac arrhythmias. Treatment involves discontinuation of the drug and administration of [[digoxin-specific antibody]] fragments if necessary.
== Related Pages ==
* [[Digitalis]]
* [[Digitalis]]
* [[Digoxin]]
* [[Heart failure]]
* [[Atrial fibrillation]]
* [[Cardiac glycoside]]
* [[Cardiac glycoside]]
* [[Heart failure]]
== References ==
<references />
[[Category:Cardiac glycosides]]
[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:Medicine]]


{{stub}}
[[Category:Cardiac drugs]]
{{dictionary-stub1}}
[[Category:Glycosides]]

Latest revision as of 12:08, 15 February 2025

Digitoxin[edit]

Chemical structure of Digitoxin

Digitoxin is a cardiac glycoside that is derived from the Digitalis plant, commonly known as foxglove. It is used in the treatment of certain heart conditions, particularly heart failure and atrial fibrillation. Digitoxin works by increasing the force of contraction of the heart muscle, thereby improving cardiac output.

Mechanism of Action[edit]

Digitoxin exerts its effects by inhibiting the sodium-potassium pump (Na_/K_-ATPase) in cardiac cells. This inhibition leads to an increase in intracellular sodium levels, which in turn affects the sodium-calcium exchange mechanism, resulting in increased intracellular calcium. The elevated calcium levels enhance the contractility of the heart muscle, a phenomenon known as positive inotropic effect.

Pharmacokinetics[edit]

Digitoxin is characterized by its long half-life, which can range from 5 to 7 days. It is primarily metabolized in the liver and excreted in the bile. Unlike digoxin, another cardiac glycoside, digitoxin is not significantly excreted by the kidneys, making it a suitable option for patients with renal impairment.

Clinical Uses[edit]

Digitoxin is used in the management of chronic heart failure and certain types of arrhythmias, such as atrial fibrillation. It helps to control the heart rate and improve symptoms of heart failure by enhancing cardiac output.

Side Effects[edit]

Common side effects of digitoxin include nausea, vomiting, diarrhea, and dizziness. More serious side effects can occur, such as arrhythmias, bradycardia, and digitalis toxicity. Monitoring of blood levels and clinical symptoms is essential to avoid toxicity.

Digitalis Toxicity[edit]

Digitalis toxicity is a serious condition that can occur with digitoxin use, especially in cases of overdose or in patients with impaired metabolism. Symptoms of toxicity include gastrointestinal disturbances, confusion, visual changes, and cardiac arrhythmias. Treatment involves discontinuation of the drug and administration of digoxin-specific antibody fragments if necessary.

Related Pages[edit]